Advancing Care for Patients With Early-Stage NSCLC: Management of Immune-Related Adverse Events

Advancing Care for Patients With Early-Stage NSCLC: Management of Immune-Related Adverse Events

The treatment landscape for early-stage non-small cell lung cancer (NSCLC) has seen an exciting shift with recent advances in immunotherapy. With these advances, there is a need for management of common immune-related adverse events (irAEs). Join this expert discussion on the current guidelines and multidisciplinary strategies for monitoring and management of irAEs in patients with early-stage NSCLC.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/advancing-care-patients-early-stage-nsclc-management-immune-related-adverse
  • Start Date: 2024-02-29 06:00:00
  • End Date: 2024-02-29 06:00:00
  • Credit Details: IPCE Credits: 0.25 hours
    AAPA Category 1 Credit™️: 0.25 hours
    AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.25 hours
    Pharmacy: 0.25 hours
  • Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 33166.67 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.